
Prompt treatment with a drug combo can effectively manage chronic kidney disease in people with type 2 diabetes, a new clinical trial shows. Patients prescribed the combination of finerenone and empagliflozin experienced a 52% decrease in their urinary albumin-to-creatinine ratio, researchers report in the New England Journal of Medicine. An elevated ratio is a sign… read on > read on >